Transdermal lidocaine as treatment for chronic subjective tinnitus: A pilot study

Daniel C. O'Brien, Aaron D. Robinson, Nancy Wang, Rodney C Diaz

Research output: Contribution to journalArticle

Abstract

Objective: To assess the efficacy of transdermal lidocaine as a treatment for chronic subjective tinnitus as measured by the Tinnitus Functional Index (TFI). Study design: Pilot, prospective efficacy trial. Setting: Tertiary care hospital. Patients: Men and women, over the age of 18 with chronic subjective tinnitus for >6 months. Intervention: Daily application of commercially available transdermal lidocaine patch. Outcome measure: Change in the TFI. Results: The average pre-treatment TFI score was 56.2. After 1 month the average TFI decreased to 41 (p < 0.05). The scores dropped to 34 and 35 after 2 and 3 months of treatment respectively. Despite improvement in symptoms of tinnitus, most patients did not continue the study after the first month, dropping out due to the size, discomfort, and appearance of the lidocaine patch, failure to follow-up and lack of perceived benefit from treatment. Conclusions: In this preliminary study, 5% transdermal lidocaine appears to be a potential treatment for chronic subjective tinnitus. The majority of subjects who completed 1 month of treatment had clinically significantly improved tinnitus. These findings are confounded however by the small sample size and significant drop out rate.

Fingerprint

Tinnitus
Lidocaine
Therapeutics
Transdermal Patch
Tertiary Healthcare
Tertiary Care Centers
Sample Size
Outcome Assessment (Health Care)

Keywords

  • Clinical trial
  • Lidocaine
  • Tinnitus

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Transdermal lidocaine as treatment for chronic subjective tinnitus : A pilot study. / O'Brien, Daniel C.; Robinson, Aaron D.; Wang, Nancy; Diaz, Rodney C.

In: American Journal of Otolaryngology - Head and Neck Medicine and Surgery, 01.01.2019.

Research output: Contribution to journalArticle

@article{ac13f9a7b2604279a82d505cceec1718,
title = "Transdermal lidocaine as treatment for chronic subjective tinnitus: A pilot study",
abstract = "Objective: To assess the efficacy of transdermal lidocaine as a treatment for chronic subjective tinnitus as measured by the Tinnitus Functional Index (TFI). Study design: Pilot, prospective efficacy trial. Setting: Tertiary care hospital. Patients: Men and women, over the age of 18 with chronic subjective tinnitus for >6 months. Intervention: Daily application of commercially available transdermal lidocaine patch. Outcome measure: Change in the TFI. Results: The average pre-treatment TFI score was 56.2. After 1 month the average TFI decreased to 41 (p < 0.05). The scores dropped to 34 and 35 after 2 and 3 months of treatment respectively. Despite improvement in symptoms of tinnitus, most patients did not continue the study after the first month, dropping out due to the size, discomfort, and appearance of the lidocaine patch, failure to follow-up and lack of perceived benefit from treatment. Conclusions: In this preliminary study, 5{\%} transdermal lidocaine appears to be a potential treatment for chronic subjective tinnitus. The majority of subjects who completed 1 month of treatment had clinically significantly improved tinnitus. These findings are confounded however by the small sample size and significant drop out rate.",
keywords = "Clinical trial, Lidocaine, Tinnitus",
author = "O'Brien, {Daniel C.} and Robinson, {Aaron D.} and Nancy Wang and Diaz, {Rodney C}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.amjoto.2019.03.009",
language = "English (US)",
journal = "American Journal of Otolaryngology - Head and Neck Medicine and Surgery",
issn = "0196-0709",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Transdermal lidocaine as treatment for chronic subjective tinnitus

T2 - A pilot study

AU - O'Brien, Daniel C.

AU - Robinson, Aaron D.

AU - Wang, Nancy

AU - Diaz, Rodney C

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: To assess the efficacy of transdermal lidocaine as a treatment for chronic subjective tinnitus as measured by the Tinnitus Functional Index (TFI). Study design: Pilot, prospective efficacy trial. Setting: Tertiary care hospital. Patients: Men and women, over the age of 18 with chronic subjective tinnitus for >6 months. Intervention: Daily application of commercially available transdermal lidocaine patch. Outcome measure: Change in the TFI. Results: The average pre-treatment TFI score was 56.2. After 1 month the average TFI decreased to 41 (p < 0.05). The scores dropped to 34 and 35 after 2 and 3 months of treatment respectively. Despite improvement in symptoms of tinnitus, most patients did not continue the study after the first month, dropping out due to the size, discomfort, and appearance of the lidocaine patch, failure to follow-up and lack of perceived benefit from treatment. Conclusions: In this preliminary study, 5% transdermal lidocaine appears to be a potential treatment for chronic subjective tinnitus. The majority of subjects who completed 1 month of treatment had clinically significantly improved tinnitus. These findings are confounded however by the small sample size and significant drop out rate.

AB - Objective: To assess the efficacy of transdermal lidocaine as a treatment for chronic subjective tinnitus as measured by the Tinnitus Functional Index (TFI). Study design: Pilot, prospective efficacy trial. Setting: Tertiary care hospital. Patients: Men and women, over the age of 18 with chronic subjective tinnitus for >6 months. Intervention: Daily application of commercially available transdermal lidocaine patch. Outcome measure: Change in the TFI. Results: The average pre-treatment TFI score was 56.2. After 1 month the average TFI decreased to 41 (p < 0.05). The scores dropped to 34 and 35 after 2 and 3 months of treatment respectively. Despite improvement in symptoms of tinnitus, most patients did not continue the study after the first month, dropping out due to the size, discomfort, and appearance of the lidocaine patch, failure to follow-up and lack of perceived benefit from treatment. Conclusions: In this preliminary study, 5% transdermal lidocaine appears to be a potential treatment for chronic subjective tinnitus. The majority of subjects who completed 1 month of treatment had clinically significantly improved tinnitus. These findings are confounded however by the small sample size and significant drop out rate.

KW - Clinical trial

KW - Lidocaine

KW - Tinnitus

UR - http://www.scopus.com/inward/record.url?scp=85063057930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063057930&partnerID=8YFLogxK

U2 - 10.1016/j.amjoto.2019.03.009

DO - 10.1016/j.amjoto.2019.03.009

M3 - Article

C2 - 30905472

AN - SCOPUS:85063057930

JO - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

JF - American Journal of Otolaryngology - Head and Neck Medicine and Surgery

SN - 0196-0709

ER -